Association analysis of 29,956 individuals confirms that a low-frequency variant at CCND2 halves the risk of type 2 diabetes by enhancing insulin secretion
Hanieh Yaghootkar, Alena Stancáková, Rachel M. Freathy, Jagadish Vangipurapu, Michael N. Weedon, Weijia Xie, Andrew R. Wood, Ele Ferrannini, Andrea Mari, Susan M. Ring, Debbie A. Lawlor, George Davey Smith, Torben Jørgensen, Torben Hansen, Oluf Pedersen, Valgerdur Steinthorsdottir, Daniel F. Guðbjartsson, Gudmar Thorleifsson, Unnur Thorsteinsdottir, Kari StefanssonAndrew T. Hattersley, Mark Walker, Andrew D. Morris, Mark I. McCarthy, Colin N. A. Palmer, Markku Laakso, Timothy M. Frayling (Lead / Corresponding author)
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Association analysis of 29,956 individuals confirms that a low-frequency variant at CCND2 halves the risk of type 2 diabetes by enhancing insulin secretion'. Together they form a unique fingerprint.